Bolt Biotherapeutics (BOLT) Earnings Date & Reports
A.I. Advisor
published Earnings
BOLT is expected to report earnings to fall 38.21% to -34 cents per share on November 07
Q3'24
Est.
$-0.35
Q2'24
Missed
by $0.10
Q1'24
Beat
by $0.23
Q4'23
Est.
$-0.47
Q3'23
Beat
by $0.07
The last earnings report on August 13 showed earnings per share of -56 cents, missing the estimate of -45 cents. With 244.67K shares outstanding, the current market capitalization sits at 23.74M.